Globus Medical Statistics
Total Valuation
Globus Medical has a market cap or net worth of $11.38 billion. The enterprise value is $11.21 billion.
| Market Cap | 11.38B |
| Enterprise Value | 11.21B |
Important Dates
The last earnings date was Tuesday, November 5, 2024, after market close.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Globus Medical has 136.17 million shares outstanding. The number of shares has increased by 25.87% in one year.
| Current Share Class | 113.74M |
| Shares Outstanding | 136.17M |
| Shares Change (YoY) | +25.87% |
| Shares Change (QoQ) | +0.79% |
| Owned by Insiders (%) | 16.95% |
| Owned by Institutions (%) | 81.88% |
| Float | 112.83M |
Valuation Ratios
The trailing PE ratio is 124.56 and the forward PE ratio is 25.80. Globus Medical's PEG ratio is 1.83.
| PE Ratio | 124.56 |
| Forward PE | 25.80 |
| PS Ratio | 4.59 |
| Forward PS | 4.30 |
| PB Ratio | 2.79 |
| P/TBV Ratio | 6.34 |
| P/FCF Ratio | 38.74 |
| P/OCF Ratio | 27.43 |
| PEG Ratio | 1.83 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.20, with an EV/FCF ratio of 38.16.
| EV / Earnings | 122.51 |
| EV / Sales | 4.52 |
| EV / EBITDA | 17.20 |
| EV / EBIT | 28.38 |
| EV / FCF | 38.16 |
Financial Position
The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.51 |
| Quick Ratio | 1.57 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.78 |
| Debt / FCF | 1.83 |
| Interest Coverage | 52.08 |
Financial Efficiency
Return on equity (ROE) is 2.22% and return on invested capital (ROIC) is 5.30%.
| Return on Equity (ROE) | 2.22% |
| Return on Assets (ROA) | 4.73% |
| Return on Capital (ROIC) | 5.30% |
| Revenue Per Employee | $495,719 |
| Profits Per Employee | $18,303 |
| Employee Count | 5,000 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 1.01 |
Taxes
In the past 12 months, Globus Medical has paid $29.54 million in taxes.
| Income Tax | 29.54M |
| Effective Tax Rate | 24.40% |
Stock Price Statistics
The stock price has increased by +83.43% in the last 52 weeks. The beta is 1.17, so Globus Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +83.43% |
| 50-Day Moving Average | 74.16 |
| 200-Day Moving Average | 65.02 |
| Relative Strength Index (RSI) | 70.06 |
| Average Volume (20 Days) | 1,077,619 |
Short Selling Information
The latest short interest is 2.86 million, so 2.10% of the outstanding shares have been sold short.
| Short Interest | 2.86M |
| Short Previous Month | 3.41M |
| Short % of Shares Out | 2.10% |
| Short % of Float | 2.53% |
| Short Ratio (days to cover) | 4.29 |
Income Statement
In the last 12 months, Globus Medical had revenue of $2.48 billion and earned $91.51 million in profits. Earnings per share was $0.67.
| Revenue | 2.48B |
| Gross Profit | 1.66B |
| Operating Income | 395.04M |
| Pretax Income | 66.55M |
| Net Income | 91.51M |
| EBITDA | 652.00M |
| EBIT | 395.04M |
| Earnings Per Share (EPS) | $0.67 |
Balance Sheet
The company has $694.71 million in cash and $536.30 million in debt, giving a net cash position of $170.70 million or $1.25 per share.
| Cash & Cash Equivalents | 694.71M |
| Total Debt | 536.30M |
| Net Cash | 170.70M |
| Net Cash Per Share | $1.25 |
| Equity (Book Value) | 4.07B |
| Book Value Per Share | 29.94 |
| Working Capital | 1.24B |
Cash Flow
In the last 12 months, operating cash flow was $414.97 million and capital expenditures -$121.20 million, giving a free cash flow of $293.77 million.
| Operating Cash Flow | 414.97M |
| Capital Expenditures | -121.20M |
| Free Cash Flow | 293.77M |
| FCF Per Share | $2.16 |
Margins
Gross margin is 67.05%, with operating and profit margins of 15.94% and 3.69%.
| Gross Margin | 67.05% |
| Operating Margin | 15.94% |
| Pretax Margin | 4.88% |
| Profit Margin | 3.69% |
| EBITDA Margin | 26.31% |
| EBIT Margin | 15.94% |
| FCF Margin | 7.20% |
Dividends & Yields
Globus Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.87% |
| Shareholder Yield | -25.87% |
| Earnings Yield | 0.80% |
| FCF Yield | 2.58% |
Analyst Forecast
The average price target for Globus Medical is $86.15, which is 3.06% higher than the current price. The consensus rating is "Buy".
| Price Target | $86.15 |
| Price Target Difference | 3.06% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 17.59% |
| EPS Growth Forecast (5Y) | 37.52% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Globus Medical has an Altman Z-Score of 6.03 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.03 |
| Piotroski F-Score | 5 |